BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 38621339)

  • 1. Safety and efficacy of percutaneous cryoablation for primary and metastatic pleural based tumors.
    Alexander ES; Petre EN; Offin M; Zauderer M; Zhao K; Sotirchos V; Solomon SB; Ziv E
    Eur J Radiol; 2024 Jun; 175():111465. PubMed ID: 38621339
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Percutaneous Cryoablation for the Treatment of Recurrent Malignant Pleural Mesothelioma: Safety, Early-Term Efficacy, and Predictors of Local Recurrence.
    Abtin F; Quirk MT; Suh RD; Hsu W; Han SX; Kim GJ; Genshaft S; Sandberg JK; Olevsky O; Cameron RB
    J Vasc Interv Radiol; 2017 Feb; 28(2):213-221. PubMed ID: 27979596
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Percutaneous Cryoablation for the Treatment of Primary and Metastatic Lung Tumors: Identification of Risk Factors for Recurrence and Major Complications.
    McDevitt JL; Mouli SK; Nemcek AA; Lewandowski RJ; Salem R; Sato KT
    J Vasc Interv Radiol; 2016 Sep; 27(9):1371-1379. PubMed ID: 27321886
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of Percutaneous Image-Guided Microwave Ablation and Cryoablation for Sarcoma Lung Metastases: A 10-Year Experience.
    Bourgouin PP; Wrobel MM; Mercaldo ND; Murphy MC; Leppelmann KS; Levesque VM; Muniappan A; Silverman SG; Shepard JO; Shyn PB; Fintelmann FJ
    AJR Am J Roentgenol; 2022 Mar; 218(3):494-504. PubMed ID: 34612679
    [No Abstract]   [Full Text] [Related]  

  • 5. Efficacy and Safety of Percutaneous Argon-Helium Cryoablation for Hepatocellular Carcinoma Abutting the Diaphragm.
    Yang Y; Zhang Y; Wu Y; Chen J; Liang B; Chen Q; Wang Q; Lyu J; Li Y; Mu F; Du D
    J Vasc Interv Radiol; 2020 Mar; 31(3):393-400.e1. PubMed ID: 31987705
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Percutaneous Cryoablation: Safety and Efficacy for Pain Palliation of Metastases to Pleura and Chest Wall.
    Fintelmann FJ; Braun P; Mirzan SH; Huang AJ; Best TD; Keyes CM; Choy E; Leppelmann KS; Muniappan A; Soto DE; Som A; Uppot RN
    J Vasc Interv Radiol; 2020 Feb; 31(2):294-300. PubMed ID: 31899108
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Active Versus Passive Thaw After Percutaneous Cryoablation of Pulmonary Tumors: Effect on Incidence, Grade, and Onset of Hemoptysis.
    Wrobel MM; Bourgouin PP; Abrishami Kashani M; Leppelmann KS; Vazquez R; Pachamanova DA; Fintelmann FJ
    AJR Am J Roentgenol; 2021 Nov; 217(5):1153-1163. PubMed ID: 34008999
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clinical Investigation on CT guided cryoablation for treating invasive chest wall or pleural tumors].
    Wang M; Pan YW; Zhou ZG; Cui Y; Du KP; Li S
    Zhonghua Zhong Liu Za Zhi; 2017 May; 39(5):395-399. PubMed ID: 28535660
    [No Abstract]   [Full Text] [Related]  

  • 9. Percutaneous Cryoablation of Clinical T2 (> 7 cm) Renal Masses: Technical Considerations, Complications, and Short-Term Outcomes.
    Moynagh MR; Schmit GD; Thompson RH; Boorjian SA; Woodrum DA; Curry TB; Atwell TD
    J Vasc Interv Radiol; 2015 Jun; 26(6):800-6. PubMed ID: 25840835
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Percutaneous cryoablation for inoperable malignant lung tumors: midterm results.
    Chou HP; Chen CK; Shen SH; Sheu MH; Wu MH; Wu YC; Chang CY
    Cryobiology; 2015 Feb; 70(1):60-5. PubMed ID: 25541142
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multicenter Study of Metastatic Lung Tumors Targeted by Interventional Cryoablation Evaluation (SOLSTICE).
    Callstrom MR; Woodrum DA; Nichols FC; Palussiere J; Buy X; Suh RD; Abtin FG; Pua BB; Madoff DC; Bagla SL; Papadouris DC; Fernando HC; Dupuy DE; Healey TT; Moore WH; Bilfinger TV; Solomon SB; Yarmohammadi H; Krebs HJ; Fulp CJ; Hakime A; Tselikas L; de Baere T
    J Thorac Oncol; 2020 Jul; 15(7):1200-1209. PubMed ID: 32151777
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Percutaneous cryoablation of stage T1b renal cell carcinoma: technique considerations, safety, and local tumor control.
    Atwell TD; Vlaminck JJ; Boorjian SA; Kurup AN; Callstrom MR; Weisbrod AJ; Lohse CM; Hartman WR; Stockland AH; Leibovich BC; Schmit GD; Thompson RH
    J Vasc Interv Radiol; 2015 Jun; 26(6):792-9. PubMed ID: 25824313
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Percutaneous cryoablation of lung tumors: feasibility and safety.
    Inoue M; Nakatsuka S; Yashiro H; Ito N; Izumi Y; Yamauchi Y; Hashimoto K; Asakura K; Tsukada N; Kawamura M; Nomori H; Kuribayashi S
    J Vasc Interv Radiol; 2012 Mar; 23(3):295-302; quiz 305. PubMed ID: 22265246
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Percutaneous CT- and MRI-guided Cryoablation of cT1 Renal Cell Carcinoma: Intermediate- to Long-term Outcomes in 307 Patients.
    Bhagavatula SK; Tuncali K; Shyn PB; Levesque VM; Chang SL; Silverman SG
    Radiology; 2020 Sep; 296(3):687-695. PubMed ID: 32633677
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Percutaneous cryoablation of renal masses >or=3 cm: efficacy and safety in treatment of 108 patients.
    Schmit GD; Atwell TD; Callstrom MR; Farrell MA; Leibovich BC; Patterson DE; Chow GK; Blute ML; Charboneau JW
    J Endourol; 2010 Aug; 24(8):1255-62. PubMed ID: 20380510
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Hopeless Case? Palliative Cryoablation and Cementoplasty Procedures for Palliation of Large Pelvic Bone Metastases.
    Coupal TM; Pennycooke K; Mallinson PI; Ouellette HA; Clarkson PW; Hawley P; Munk PL
    Pain Physician; 2017 Nov; 20(7):E1053-E1061. PubMed ID: 29149150
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and Oncologic Outcomes of Percutaneous Cryoablation of Renal Cell Carcinoma Recurrences in the Ipsilateral Kidney Following Partial Nephrectomy.
    Rossi J; Cazzato RL; de Marini P; Auloge P; Autrusseau PA; Dalili D; Tricard T; Poussot B; Garnon J; Lang H; Gangi A
    Cardiovasc Intervent Radiol; 2022 May; 45(5):656-664. PubMed ID: 35274173
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Percutaneous cryoablation of pulmonary metastases from colorectal cancer.
    Yamauchi Y; Izumi Y; Kawamura M; Nakatsuka S; Yashiro H; Tsukada N; Inoue M; Asakura K; Nomori H
    PLoS One; 2011; 6(11):e27086. PubMed ID: 22096520
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complications of Percutaneous Bone Tumor Cryoablation: A 10-year Experience.
    Auloge P; Cazzato RL; Rousseau C; Caudrelier J; Koch G; Rao P; Chiang JB; Garnon J; Gangi A
    Radiology; 2019 May; 291(2):521-528. PubMed ID: 30806603
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Percutaneous cryoablation of 40 solid renal tumors with US guidance and CT monitoring: initial experience.
    Atwell TD; Farrell MA; Callstrom MR; Charboneau JW; Leibovich BC; Patterson DE; Chow GK; Blute ML
    Radiology; 2007 Apr; 243(1):276-83. PubMed ID: 17329689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.